ZYUS Life Sciences Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for ZYUS Life Sciences.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 66.0% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 May 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 0 | N/A | -6 | -21 | 1 |
| 12/31/2023 | 0 | -43 | -18 | -18 | N/A |
| 9/30/2023 | 0 | -24 | -17 | -17 | N/A |
| 6/30/2023 | 0 | -27 | -5 | -4 | N/A |
| 3/31/2023 | 0 | -24 | -9 | -8 | N/A |
| 12/31/2022 | 0 | -25 | -10 | -10 | N/A |
| 9/30/2022 | 0 | -26 | -12 | -11 | N/A |
| 12/31/2021 | 0 | -23 | -22 | -17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ZYUS's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if ZYUS's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if ZYUS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ZYUS's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if ZYUS's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ZYUS's Return on Equity is forecast to be high in 3 years time